Sanofi (LON:0O59)

Market Cap	87.57B
Revenue (ttm)	39.21B
Net Income (ttm)	7.82B
Shares Out	n/a
EPS (ttm)	6.31
PE Ratio	11.19
Forward PE	10.23
Dividend	3.30 (4.08%)
Ex-Dividend Date	May 12, 2025

Volume	471,639
Average Volume	479,139
Open	82.40
Previous Close	81.65
Day's Range	81.98 - 83.47
52-Week Range	76.78 - 110.84
Beta	0.41
RSI	45.85
Earnings Date	Jul 31, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O59

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR